C

Celltrion Pharm Inc
KOSDAQ:068760

Watchlist Manager
Celltrion Pharm Inc
KOSDAQ:068760
Watchlist
Price: 53 000 KRW 0.76% Market Closed
Market Cap: 2.2T KRW
Have any thoughts about
Celltrion Pharm Inc?
Write Note
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

437.4B
+9%
Revenue
Growth Rates:
1 Year
+15%
3 Years
+24%
5 Years
+144%
7 Years
+238%
10 Years
+574%
29.3B
+32%
Operating Income
Growth Rates:
1 Year
-21%
3 Years
-38%
5 Years
+189%
7 Years
+244%
10 Years
+319%
16.5B
+43%
Net Income
Growth Rates:
1 Year
-38%
3 Years
-59%
5 Years
+1 851%
7 Years
+348%
10 Years
+325%

Earnings Waterfall
Celltrion Pharm Inc

Revenue
437.4B KRW
Cost of Revenue
-323.1B KRW
Gross Profit
114.3B KRW
Operating Expenses
-85B KRW
Operating Income
29.3B KRW
Other Expenses
-12.8B KRW
Net Income
16.5B KRW

Income Statement
Celltrion Pharm Inc

Rotate your device to view
Income Statement
Currency: KRW
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
64 916
N/A
66 744
+3%
70 635
+6%
72 004
+2%
71 141
-1%
74 732
+5%
76 610
+3%
82 941
+8%
85 560
+3%
104 811
+23%
109 022
+4%
116 961
+7%
129 330
+11%
135 860
+5%
141 016
+4%
141 468
+0%
141 713
+0%
146 880
+4%
158 150
+8%
166 472
+5%
179 170
+8%
173 513
-3%
179 313
+3%
183 085
+2%
201 141
+10%
233 568
+16%
274 730
+18%
327 081
+19%
352 489
+8%
398 738
+13%
401 943
+1%
408 590
+2%
421 485
+3%
386 040
-8%
387 294
+0%
392 147
+1%
381 737
-3%
388 794
+2%
395 752
+2%
402 662
+2%
437 408
+9%
Gross Profit
Cost of Revenue
(22 547)
(23 495)
(24 167)
(24 756)
(24 599)
(26 841)
(28 289)
(33 798)
(36 060)
(52 639)
(59 751)
(63 916)
(73 411)
(77 575)
(81 365)
(90 037)
(98 185)
(106 291)
(115 558)
(117 205)
(121 852)
(111 046)
(111 838)
(114 764)
(131 149)
(160 404)
(193 658)
(229 885)
(242 787)
(279 485)
(282 063)
(292 548)
(301 475)
(273 266)
(271 898)
(270 116)
(264 228)
(269 084)
(280 040)
(293 061)
(323 100)
Gross Profit
42 370
N/A
43 249
+2%
46 470
+7%
47 249
+2%
46 543
-1%
47 892
+3%
48 321
+1%
49 143
+2%
49 499
+1%
52 172
+5%
49 269
-6%
53 043
+8%
55 918
+5%
58 286
+4%
59 651
+2%
51 431
-14%
43 528
-15%
40 589
-7%
42 592
+5%
49 267
+16%
57 318
+16%
62 467
+9%
67 475
+8%
68 321
+1%
69 992
+2%
73 164
+5%
81 072
+11%
97 197
+20%
109 702
+13%
119 253
+9%
119 881
+1%
116 042
-3%
120 011
+3%
112 774
-6%
115 396
+2%
122 031
+6%
117 509
-4%
119 710
+2%
115 713
-3%
109 602
-5%
114 308
+4%
Operating Income
Operating Expenses
(35 386)
(34 900)
(37 100)
(38 388)
(38 558)
(41 517)
(41 589)
(42 248)
(42 084)
(44 903)
(45 111)
(45 881)
(47 400)
(49 615)
(48 597)
(45 584)
(43 293)
(37 020)
(38 599)
(45 361)
(47 203)
(47 731)
(50 488)
(49 229)
(49 044)
(49 535)
(52 190)
(57 433)
(62 784)
(71 455)
(73 962)
(75 893)
(79 402)
(74 604)
(75 432)
(78 151)
(80 541)
(83 639)
(88 175)
(87 420)
(85 031)
Selling, General & Administrative
(33 449)
(33 728)
(35 919)
(37 097)
(36 829)
(39 156)
(38 896)
(39 467)
(39 587)
(42 434)
(42 876)
(43 797)
(45 361)
(47 331)
(45 900)
(42 505)
(39 866)
(33 781)
(35 320)
(38 002)
(39 385)
(43 942)
(46 359)
(44 649)
(44 666)
(43 453)
(45 172)
(50 550)
(55 346)
(64 083)
(67 181)
(68 293)
(70 679)
(65 487)
(65 569)
(67 512)
(66 975)
(68 182)
(68 142)
(66 200)
(66 056)
Research & Development
(1 446)
(788)
(804)
(821)
(1 079)
(1 489)
(1 585)
(1 538)
(1 230)
(1 204)
(987)
(851)
(787)
(1 033)
(1 427)
(1 791)
(2 126)
(1 919)
(1 883)
(1 907)
(2 266)
(2 132)
(2 156)
(2 593)
(2 490)
(4 612)
(5 730)
(5 753)
(6 389)
(6 365)
(5 743)
(6 551)
(7 635)
(7 999)
(8 723)
(9 089)
(11 413)
(12 707)
(13 971)
(14 818)
(12 624)
Depreciation & Amortization
(491)
(383)
(376)
(467)
(649)
(872)
(1 107)
(1 243)
(1 266)
(1 266)
(1 249)
(1 235)
(1 253)
(1 251)
(1 270)
(1 287)
(1 300)
(1 320)
(1 395)
(1 464)
(1 565)
(1 657)
(1 668)
(1 682)
(1 583)
(1 470)
(1 287)
(1 129)
(1 049)
(1 007)
(1 038)
(1 049)
(1 089)
(1 118)
(1 141)
(1 550)
(2 153)
(2 750)
(3 395)
(3 735)
(3 683)
Other Operating Expenses
0
0
0
(3)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(3 988)
(3 987)
0
(305)
(305)
(305)
0
0
0
0
0
0
0
0
0
0
0
0
0
(2 667)
(2 667)
(2 667)
Operating Income
6 982
N/A
8 350
+20%
9 369
+12%
8 861
-5%
7 985
-10%
6 374
-20%
6 732
+6%
6 894
+2%
7 414
+8%
7 269
-2%
4 157
-43%
7 162
+72%
8 518
+19%
8 671
+2%
11 055
+27%
5 848
-47%
235
-96%
3 569
+1 419%
3 991
+12%
3 904
-2%
10 114
+159%
14 736
+46%
16 987
+15%
19 092
+12%
20 948
+10%
23 630
+13%
28 883
+22%
39 764
+38%
46 919
+18%
47 798
+2%
45 919
-4%
40 149
-13%
40 609
+1%
38 170
-6%
39 964
+5%
43 880
+10%
36 967
-16%
36 071
-2%
27 538
-24%
22 182
-19%
29 277
+32%
Pre-Tax Income
Interest Income Expense
(2 771)
(3 036)
(2 659)
(3 411)
(3 782)
(5 239)
(6 970)
(6 720)
(6 858)
(6 585)
(5 597)
(5 844)
(5 914)
(5 320)
(5 573)
(5 575)
(5 717)
(5 499)
(5 531)
(5 255)
(4 990)
(5 089)
(4 722)
(4 438)
(3 998)
(3 538)
(3 775)
(3 682)
(4 331)
(5 180)
(5 489)
(6 714)
(7 620)
(6 464)
(6 642)
(6 589)
(6 109)
(7 353)
(7 291)
(7 016)
(6 672)
Non-Reccuring Items
99
373
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(3 902)
(3 987)
0
0
(306)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(2 667)
0
0
0
Gain/Loss on Disposition of Assets
1
1
0
4
(46)
(42)
0
0
0
0
0
0
0
0
(3)
54
0
(3)
(199)
(251)
(374)
(459)
0
0
(7)
(26)
0
0
(18)
(0)
(0)
(0)
0
0
0
442
0
441
460
12
12
Total Other Income
116
222
161
73
6
(33)
(49)
(28)
53
(112)
(82)
(201)
(275)
(887)
(904)
(867)
(790)
(424)
(556)
(580)
(429)
(37)
(125)
11
37
62
44
(93)
(66)
(95)
(1 141)
(1 063)
(1 229)
(1 237)
(244)
(207)
234
(283)
(234)
(309)
(180)
Pre-Tax Income
4 429
N/A
5 910
+33%
6 873
+16%
5 528
-20%
4 163
-25%
1 060
-75%
(287)
N/A
146
N/A
609
+317%
572
-6%
(1 523)
N/A
1 116
N/A
2 328
+109%
2 464
+6%
4 575
+86%
(540)
N/A
(6 272)
-1 061%
(6 260)
+0%
(6 281)
0%
(2 181)
+65%
4 321
N/A
8 845
+105%
12 140
+37%
14 665
+21%
16 980
+16%
20 128
+19%
25 152
+25%
35 989
+43%
42 503
+18%
42 522
+0%
39 289
-8%
32 372
-18%
31 760
-2%
30 469
-4%
33 078
+9%
37 526
+13%
31 093
-17%
26 209
-16%
20 473
-22%
14 869
-27%
22 437
+51%
Net Income
Tax Provision
(556)
(40)
(298)
(1 261)
(196)
5 674
7 280
6 750
6 668
2 344
1 458
1 973
1 349
251
165
(574)
(469)
(3 129)
(3 273)
(2 829)
(3 477)
(243)
(1 595)
(2 221)
(2 576)
812
873
(621)
(2 216)
(7 944)
(7 753)
(6 528)
(6 894)
(4 509)
(4 698)
(6 129)
(4 344)
(4 944)
(4 008)
(3 376)
(5 968)
Income from Continuing Operations
3 873
5 869
6 576
4 267
3 967
6 734
6 992
6 896
7 277
2 916
(65)
3 089
3 677
2 715
4 740
(1 114)
(6 741)
(9 389)
(9 554)
(5 010)
844
8 602
10 545
12 444
14 404
20 940
26 025
35 368
40 287
34 579
31 537
25 844
24 867
25 960
28 380
31 397
26 748
21 265
16 465
11 494
16 470
Net Income (Common)
3 873
N/A
5 869
+52%
6 576
+12%
4 267
-35%
3 967
-7%
6 734
+70%
6 992
+4%
6 896
-1%
7 277
+6%
2 916
-60%
(65)
N/A
3 089
N/A
3 677
+19%
2 715
-26%
4 740
+75%
(1 114)
N/A
(6 741)
-505%
(9 389)
-39%
(9 554)
-2%
(5 010)
+48%
844
N/A
8 602
+919%
10 545
+23%
12 444
+18%
14 404
+16%
20 940
+45%
26 025
+24%
35 368
+36%
40 287
+14%
34 579
-14%
31 537
-9%
25 844
-18%
24 867
-4%
25 960
+4%
28 380
+9%
31 397
+11%
26 748
-15%
21 265
-20%
16 465
-23%
11 494
-30%
16 470
+43%
EPS (Diluted)
148.96
N/A
326.05
+119%
187.88
-42%
193.95
+3%
158.68
-18%
192.4
+21%
241.1
+25%
215.5
-11%
220.51
+2%
97.2
-56%
-1.85
N/A
81.28
N/A
102.13
+26%
75.41
-26%
128.1
+70%
-30.94
N/A
-187.25
-505%
-260.8
-39%
-258.21
+1%
-135.4
+48%
23.44
N/A
232.48
+892%
277.5
+19%
336.32
+21%
389.29
+16%
565.94
+45%
703.37
+24%
936.64
+33%
1 015.76
+8%
834.84
-18%
796.22
-5%
653.67
-18%
628.83
-4%
625.32
-1%
684.01
+9%
757.39
+11%
645.18
-15%
512.9
-21%
396.85
-23%
277.39
-30%
397.52
+43%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 202,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.